Brief: Xbrane Biopharma, JOINN Biologics US Partner To Develop Xdarzane
12/06/2026 06:35
BRIEF-Xbrane Biopharma, JOINN Biologics US Partner To Develop Xdarzane June 12 (Reuters) - Xbrane Biopharma AB XBRANE.ST:
SAID ON THURSDAY IT ENTERED STRATEGIC PARTNERSHIP WITH JOINN BIOLOGICS US TO DEVELOP XDARZANE
XDARZANE IS BIOSIMILAR CANDIDATE REFERENCING DARZALEX (DARATUMUMAB)
JOINN TO PROVIDE CUSTOMIZED PROCESS DEVELOPMENT, BE RESPONSIBLE FOR FURTHER PILOT-SCALE PROCESS DEVELOPMENT
XBRANE TO LEAD GLOBAL OUT-LICENSING ACTIVITIES TO COMMERCIAL PARTNERS
Source text for Workspace: nMFNK3GK1
Further company coverage: XBRANE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))